Search research articles
Contact Us
Filters
Showing results (51-60 of 208) with videos related to
Page
of 21
Sort By:
Nuklearmedizin. Nuclear Medicine
|
April 8, 2020
Textural features in FDG-PET/CT can predict outcome in melanoma patients to treatment with Vemurafenib and Ipililumab
Daniela Dittrich, Thomas Pyka, Klemens Scheidhauer, et al.
VASA. Zeitschrift Fur Gefasskrankheiten
|
August 31, 2013
Comparison of fluorine-18-deoxyglucose positron emission tomography/computed tomography and contrast-enhanced ultrasound in a patient with chronic periaortitis
Dominik Steubl, Klaus Thürmel, Philipp Moog, et al.
Tomography (Ann Arbor, Mich.)
|
August 27, 2021
Evaluating a Machine Learning Tool for the Classification of Pathological Uptake in Whole-Body PSMA-PET-CT Scans
Annette Erle, Sobhan Moazemi, Susanne Lütje, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 1, 2017
Assessment of Bone Metastases in Patients with Prostate Cancer-A Comparison between <sup>99m</sup>Tc-Bone-Scintigraphy and [<sup>68</sup>Ga]Ga-PSMA PET/CT
Lena Thomas, Caroline Balmus, Hojjat Ahmadzadehfar, et al.
International Journal of Cancer
|
July 2, 2009
Endogenous expression of the sodium iodide symporter mediates uptake of iodide in murine models of colorectal carcinoma
Florian C Gaertner, Franziska Rohde, Jan Mueller, et al.
Nuklearmedizin. Nuclear Medicine
|
August 22, 2020
Improving quality of life in patients with metastatic prostate cancer following one cycle of 177Lu-PSMA-617 radioligand therapy: a pilot study
Milka Marinova, Reza Alamdar, Hojjat Ahmadzadehfar, et al.
Medicine
|
September 22, 2020
Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapy
Miriam Sraieb, Nader Hirmas, Rupert Conrad, et al.
Diagnostics (Basel, Switzerland)
|
February 2, 2021
Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with <sup>177</sup>Lu-PSMA
Sobhan Moazemi, Annette Erle, Susanne Lütje, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 15, 2017
Delayed response after repeated <sup>177</sup>Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer
Kambiz Rahbar, Martin Bögeman, Anna Yordanova, et al.
Journal of Vascular Surgery
|
June 24, 2008
Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms
Christian Reeps, Markus Essler, Jaroslav Pelisek, et al.
Page
of 21
Search research articles
Search
Showing results (51-60 of 208) with videos related to
Sort By:
Page
of 21
Nuklearmedizin. Nuclear Medicine
|
April 8, 2020
Textural features in FDG-PET/CT can predict outcome in melanoma patients to treatment with Vemurafenib and Ipililumab
Daniela Dittrich, Thomas Pyka, Klemens Scheidhauer, et al.
VASA. Zeitschrift Fur Gefasskrankheiten
|
August 31, 2013
Comparison of fluorine-18-deoxyglucose positron emission tomography/computed tomography and contrast-enhanced ultrasound in a patient with chronic periaortitis
Dominik Steubl, Klaus Thürmel, Philipp Moog, et al.
Tomography (Ann Arbor, Mich.)
|
August 27, 2021
Evaluating a Machine Learning Tool for the Classification of Pathological Uptake in Whole-Body PSMA-PET-CT Scans
Annette Erle, Sobhan Moazemi, Susanne Lütje, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 1, 2017
Assessment of Bone Metastases in Patients with Prostate Cancer-A Comparison between <sup>99m</sup>Tc-Bone-Scintigraphy and [<sup>68</sup>Ga]Ga-PSMA PET/CT
Lena Thomas, Caroline Balmus, Hojjat Ahmadzadehfar, et al.
International Journal of Cancer
|
July 2, 2009
Endogenous expression of the sodium iodide symporter mediates uptake of iodide in murine models of colorectal carcinoma
Florian C Gaertner, Franziska Rohde, Jan Mueller, et al.
Nuklearmedizin. Nuclear Medicine
|
August 22, 2020
Improving quality of life in patients with metastatic prostate cancer following one cycle of 177Lu-PSMA-617 radioligand therapy: a pilot study
Milka Marinova, Reza Alamdar, Hojjat Ahmadzadehfar, et al.
Medicine
|
September 22, 2020
Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapy
Miriam Sraieb, Nader Hirmas, Rupert Conrad, et al.
Diagnostics (Basel, Switzerland)
|
February 2, 2021
Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with <sup>177</sup>Lu-PSMA
Sobhan Moazemi, Annette Erle, Susanne Lütje, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 15, 2017
Delayed response after repeated <sup>177</sup>Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer
Kambiz Rahbar, Martin Bögeman, Anna Yordanova, et al.
Journal of Vascular Surgery
|
June 24, 2008
Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms
Christian Reeps, Markus Essler, Jaroslav Pelisek, et al.
Page
of 21